Next‐Generation Proteolysis‐Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein Degradation

Documenti analoghi

• Dual‐Function Lipid‐Based Nanovector Strategy for Glioblastoma Immunotherapy: STING Activation and M1 Microglia Polarization
  di: Mohamed S. Nafie, et al.
  Pubblicazione: (2026)
• Beyond ATP Synthase Inhibition: Chemical Diversification, Bioactivities, and Therapeutic Potential of Oligomycin A
  di: Mohamed S. Nafie, et al.
  Pubblicazione: (2025)
• Lead Discovery via Scaffold Refinement: Structure‐Guided Optimization of 1,2,4‐Triazolo[1,5‐ a ]Pyrimidines as Potent Dual EGFR/CDK‐2 Inhibitors Targeting Colorectal Carcinoma
  di: Rowida Nasr, et al.
  Pubblicazione: (2026)
• Exploring Pyrazolo[3,4‐ b ]Pyridine and Spiro‐Oxindole Hybrids as Selective CDK2 or EGFR Inhibitors for Targeted Cancer Therapy: Design, Synthesis, and Molecular Modeling Insights
  di: Ahmed K. B. A. W. Farouk, et al.
  Pubblicazione: (2026)
• Lysosome‐Mediated Targeted Protein Degradation: Emerging Chimeric Platforms for Extracellular and Intracellular Therapeutics
  di: Shayan Asadi, et al.
  Pubblicazione: (2025)